Arvaya Healthcare Rights Issue (13 Nov 2026)
Arvaya Healthcare Ltd reports Q2 & H1 FY 2026-27 unaudited financial results and approves rights issue
Arvaya Healthcare · Commercial Services & Supplies
Key highlights
- Approved proposed rights issue of partly paid-up equity shares up to ₹210 crore on July 11, 2026; Rights Issue Committee authorized Nov 4, 2026
- Allotted 38,71,854 fully paid equity shares at ₹40 each on preferential basis to 47 shareholders of Sushodha Institute of Gastroenterology Pvt Ltd on Oct 24, 2026
- Completed acquisition of 1,84,374 equity shares (100%) of Sushodha Institute on Nov 1, 2026, making it wholly owned subsidiary via share swap
Original filing
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th November 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Arvaya Healthcare
- Financial resultsArvaya Healthcare Ltd announces Q2 FY2026-27 financials, rights issue, and acquisition
- Fundraise / allotmentNotableArvaya Healthcare Limited approves Draft Letter of Offer for ₹205.8 crore Rights Issue
- Fundraise / allotmentNotableArvaya Healthcare Limited revises Rights Issue committee authorisation details
- Fundraise / allotmentNotableArvaya Healthcare Limited proposes Rights Issue of Equity Shares up to ₹210 Cr
- Acquisition / mergerNotableArvaya Healthcare Limited completes acquisition of 100% equity of SIGPL
Other acquisition / merger filings this fortnight
- Acquisition / mergerGSP Crop ScienceGSP Crop Science Limited Q2 FY2027 financial results and corporate updates disclosed
- Acquisition / mergerGSP Crop ScienceGSP Crop Science Limited reports Q2 2026 financials and management changes
- Acquisition / mergerLinde IndiaLinde India acquires 100% stake in Airtech Cryogenic Gases Pvt Ltd for ₹111.20 crore
- Acquisition / mergerManipal Health EnterprisesManipal Health Enterprises completes acquisition of Kinder Women’s Hospital
- Acquisition / mergerPramodini MedicarePramodini Medicare Ltd reports H1 FY2027 financials and IPO funds utilization
- Acquisition / mergerPramodini MedicarePramodini Medicare Ltd reports Q2 FY27 financials and IPO fund utilization
Potential multibaggers · Q2 FY27
Potential multibaggers in Commercial Services & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.